Evidence map›Paper›PMID 40236776›Full record

ArticleiMeta2025

Gut microbiota in cancer: From molecular mechanisms to precision medicine applications.

Weihua Xiao, Qiong Chen, Chunjiao Liu, Yueer Yu, Tianliang Liu, Yang Jin, Haifen Ma, Shifu Chen, Chao Jiang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iMeta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Weihua XiaoDepartment of Pathology, Beilun Branch of the First Affiliated Hospital, College of Medicine Zhejiang University Ningbo China.ORCID 0000-0002-9756-312X
Qiong ChenMOE Key Laboratory of Biosystems Homeostasis & Protection, and Zhejiang Key Laboratory of Molecular Cancer Biology, Life Sciences Institute Zhejiang University Hangzhou China.ORCID 0009-0004-4369-5620
Chunjiao LiuDepartment of Pathology, Beilun Branch of the First Affiliated Hospital, College of Medicine Zhejiang University Ningbo China.
Yueer YuDepartment of Tea Research Institute Zhejiang University Hangzhou China.
Tianliang LiuHaploX Biotechnology Shenzhen China.
Yang JinInstitute for Cancer Genetics and Informatics Oslo University Hospital Oslo Norway.
Haifen MaDepartment of Pathology, Beilun Branch of the First Affiliated Hospital, College of Medicine Zhejiang University Ningbo China.
Shifu ChenHaploX Biotechnology Shenzhen China.ORCID 0000-0001-5799-653X
Chao JiangMOE Key Laboratory of Biosystems Homeostasis & Protection, and Zhejiang Key Laboratory of Molecular Cancer Biology, Life Sciences Institute Zhejiang University Hangzhou China.ORCID 0000-0003-0260-7271

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota-cancer interaction functions through multi-level biological mechanisms, forming the basis for both diagnostic and therapeutic applications. Current technical and biological challenges drive the field toward precision medicine approaches, aiming to integrate multi-dimensional data for optimized, personalized cancer treatments.

Identifiers

PMID40236776
PMCPMC11995170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.